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Abstract Phospholipase C (PLC) activation in neonatal rat
ventricular cardiomyocytes (NRVM) generates inositol(1,4,5)-
trisphosphate (Ins(1,4,5)P3) in response to elevations in Ca
2+
or inositol(1,4)bisphosphate in response to G protein stimula-
tion. Overexpression of PLCN1 increased total [3H]inositol
phosphate (InsP) content and elevated [3H]Ins(1,4,5)P3, but
failed to increase [3H]InsP responses to the Ca2+ ionophore
A23187. Antisense PLCN1 expression reduced endogenous
PLCN1 content but did not decrease the A23187 response. In
permeabilized NRVM, [3H]InsP responses to elevated Ca2+
were not inhibited by Ins(1,4,5)P3, even at concentrations
1000-fold greater than required for selective inhibition
of PLCN1. Taken together these data provide evidence that
PLCN1 does not mediate the InsP response to elevated Ca
2+
in NRVM.
7 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Receptor stimulation of phosphatidylinositol (PtdIns)-spe-
ci¢c phospholipase C (PLC) causes generation of sn-1,2-diac-
ylglycerol, which is able to activate protein kinase C isoforms
[1], and inositol(1,4,5)trisphosphate (Ins(1,4,5)P3), which re-
leases Ca2þ from intracellular stores [2]. Studies from our lab-
oratory using intact heart and isolated cardiomyocytes have
shown, however, that unlike responses in other cell types, K1-
adrenergic stimulation generates principally inositol(1,4)bis-
phosphate (Ins(1,4)P2) which has no Ca2þ-mobilizing function
[3,4]. In marked contrast, increased intracellular Ca2þ itself
stimulates robust Ins(1,4,5)P3 responses [4]. Ins(1,4,5)P3
generation in the heart is arrhythmogenic [5^10], although
the mechanisms involved have not been fully explained.
Ins(1,4,5)P3 receptors are expressed at low levels in ventricular
myocardium [11], but it is possible that activation of these
receptors causes localized Ca2þ release. Even local changes
in Ca2þ could lead to perturbations in Ca2þ homeostasis
[12] in cells whose Ca2þ levels are otherwise ¢nely regulated
during each depolarization/contraction cycle by mechanisms
that do not involve Ins(1,4,5)P3, e.g. voltage-dependent Ca2þ
in£ux, the ryanodine receptor system and Naþ/Ca2þ ex-
change. The ¢nding that increased intracellular Ca2þ itself
can initiate an Ins(1,4,5)P3 response increases the likelihood
that disturbances of Ca2þ homeostasis will be self-perpetuat-
ing, leading to arrhythmias and sudden cardiac death. We
therefore sought to identify the mechanisms responsible for
Ca2þ-activated Ins(1,4,5)P3 generation in cardiomyocytes.
The well-known classes of mammalian PtdIns-speci¢c PLC
enzymes are L, Q and N, and a new class PLCO has recently
been identi¢ed [13,14]. All PLC isozymes are activated by
Ca2þ in vitro but of these, PLCN1 is the most sensitive to
Ca2þ and is considered the most likely to be activated by
increases in Ca2þ alone over the concentration range encoun-
tered in cardiomyocytes [15^17].
In the current study we investigated the role of PLCN1 in
mediating Ca2þ-induced inositol phosphate (InsP) responses
in neonatal rat cardiomyocytes (NRVM).
2. Materials and methods
2.1. Culture of neonatal cardiomyocytes
Neonatal cardiomyocyte (NRVM) cultures were prepared from 1^
3-day-old Sprague^Dawley rat pups as previously described [4].
NRVM were isolated by repeated trypsin digestion with gentle me-
chanical dispersion, pre-plated twice for 30 min each to remove non-
myocytes and left to attach for 18 h in Dulbecco’s modi¢ed Eagle’s
medium (DMEM), 10% fetal calf serum, 0.1 mM bromodeoxyuridine
(BrdU), 50 U/ml penicillin G and 50 Wg/ml streptomycin sulfate onto
uncoated dishes, at a typical seeding density of 800 cells/mm2. Me-
dium was then replaced with a de¢ned serum-free medium consisting
of DMEM, 10 Wg/ml human insulin, 10 Wg/ml bovine apo-transferrin,
0.1 mM BrdU, 50 U/ml penicillin G, 50 Wg/ml streptomycin sulfate
and 125 Wg/ml fungizone. BrdU was omitted after 3 days. NRVM
were treated with adenovirus and labeled with [3H]inositol in de¢ned
inositol-free, serum-free medium for 48 h prior to experiments. Wells
were washed thoroughly with non-radioactive medium before use.
2.2. Preparation of adenoviruses and infection of NRVM
Rat PLCN1 cloned into the NotI site of pZipNeo and the rat PLCQ1
plasmid were gifts from Dr. S.G. Rhee [18]. The NotI restriction frag-
ment corresponding to PLCN1 was subcloned into the plasmid
pxcx3.CMV in the sense and antisense orientations. These constructs
were cotransfected into HEK293 cells with pJM17 (modi¢ed adeno-
virus backbone) and cultures were overlaid with agarose. Following
recombination, individual plaques were selected and puri¢ed through
sequential rounds of infection and agarose overlay. High titer viral
stocks were puri¢ed on CsCl gradients.
Adenoviruses were used at a multiplicity of infection of 100 plaque-
forming units (pfu)/cell. As described in other cell types [19], overex-
pressed PLC enzymes were active as shown by increased PLC activity
in extracts prepared from infected NRVM.
2.3. Protein analysis
NRVM infected with adenoviruses were washed twice in ice-cold
phosphate-bu¡ered saline, followed by the addition of an ice-cold lysis
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bu¡er at pH 7.7 containing the following constituents (in mM): Tris^
HCl 20, NaCl 150, EDTA 2, EGTA 2, L-glycerophosphate 20, sodium
orthovanadate 1, with 10% glycerol and 0.5% Nonidet P-40, and
1 mM dithiothreitol, 1 mM phenylmethylsulfonyl £uoride, 1 WM pep-
statin A, 5 Wg/ml aprotinin and 10 Wg/ml leupeptin as protease inhib-
itors. Wells were scraped and the DNA sheared using a 27-gauge
needle. Lysates were cleared by centrifugation and protein content
of the supernatants measured by the Bradford method [20] with bo-
vine serum albumin as standard and using a dye reagent from Bio-
Rad.
Proteins (40 Wg) from whole-cell lysates were separated on 7.5%
denaturing polyacrylamide gels [21] and electrophoretically trans-
ferred to nitrocellulose membranes from Schleicher and Schuell (Das-
sel, Germany). Nitrocellulose membranes were stained with Ponceau-
S (Sigma) to con¢rm equal protein loading per lane and equal transfer
e⁄ciency, then blocked for 1 h in 5% non-fat dry milk and probed
with appropriate antibodies. Enhanced chemiluminescence detection
was carried out according to the manufacturer’s instructions (Amer-
sham Biosciences).
Mouse monoclonal anti-PLCN1 antibody was from Upstate Bio-
technology (Lake Placid, NY, USA) and used at a ¢nal concentration
of 0.4 Wg/ml.
2.4. Generation and extraction of [3H]InsPs
[3H]Inositol-labeled (48 h, 10 WCi/ml) NRVM were washed with
unlabeled medium and pretreated with 10 mM LiCl in DMEM for
10 min prior to the addition of Ca2þ ionophore (A23187, 10 WM). For
experiments involving permeabilized cells, [3H]inositol-labeled NRVM
were permeabilized by treatment with saponin (50 Wg/ml) for 4 min at
37‡C in ‘intracellular’ salts medium containing an ATP-generating
system, followed by four washes in ‘intracellular’ medium. ‘Intracel-
lular’ medium contained (in mM): KCl, 110; NaCl, 10; KH2PO4, 1;
MgSO4, 5; EGTA, 1; HEPES, 20; ATP, 2; creatine phosphate, 10;
with 20 U creatine phosphokinase (Sigma). CaCl2 was added to pro-
vide a free Ca2þ of 0.1 WM (basal) or 10 WM (Ca2þ-activated). CaCl2
additions were calculated using a Ca2þ^EGTA titration curve. Fresh
‘intracellular’ medium containing 10 mM LiCl was added for 10 min,
prior to increases in Ca2þ. After stimulation, [3H]InsPs were extracted
with ice-cold 5% trichloroacetic acid (TCA)/2.5 mM EDTA/5 mM
sodium phytate and the supernatants subsequently treated with a
1:1 mixture of 1,1,2-trichlorotri£uoroethane:tri-n-octylamine to re-
move remaining TCA. The aqueous phase containing [3H]InsPs was
prepared for high performance liquid chromatography to separate
individual isomers [22], or was subjected to chromatography on Dow-
ex 1 columns for total [3H]InsP measurement [23].
2.5. Inositol polyphosphate 1-phosphatase
Inositol polyphosphate 1-phosphatase (INPP) activity was assayed
using 10 WM [3H]Ins(1,4)P2 (10 cpm/pmol) as substrate in 100 mM
KCl, 2 mM MgSO4, 0.5 mM EDTA, 1 mM glucose 6-phosphate and
50 mM HEPES, pH 7.4. Reactions were carried out at 37‡C for 5 min
and terminated by the addition of 50 mM ammonium formate,
200 mM formic acid. [3H]Ins(1,4)P2 and [3H]Ins(4)P1 were separated
on Dowex 1 (formate) columns [24,25] and [3H]InsP1 measured by
liquid scintillation counting.
2.6. Materials
Fetal calf serum used during NRVM isolation was specially selected
for low endotoxin and obtained from the Commonwealth Serum Lab-
oratories (Parkville, Australia). DMEM, HEPES, and other materials
for the preparation of cell culture solutions and media were cell cul-
ture grade, obtained from Sigma and dissolved in milli-Q H2O.
[3H]Inositol (18.00 Ci/mmol) was obtained from Amersham Bioscien-
ces, [3H]inositol(1,4)bisphosphate (INS(1,4)P2, 6.5 Ci/mmol) was from
New England Nuclear (Boston, MA, USA), Ins(1,4,5)P3 (sodium salt)
was obtained through Sigma, A23187 (free acid) was supplied by
Calbiochem. Other reagents were obtained from Sigma or BDH/Ana-
laR and were of analytical reagent grade.
2.7. Treatment of data
Di¡erences between treatment groups were assessed by unpaired
Student’s t-test or one-way analysis of variance with Tukey’s test
for multiple comparisons, and accepted as statistically signi¢cant at
P6 0.05. Unless otherwise noted in ¢gure legends, results shown are
from representative experiments performed in triplicate, which were
repeated independently three times.
3. Results
3.1. Overexpressed PLCN1 increases Ins(1,4,5)P3 and total
InsPs
PLCN isoforms bind both PIP2 and Ins(1,4,5)P3 with high
a⁄nity, and the association with PIP2 would be expected to
target PLCN to the sarcolemma in the absence of other stim-
uli. We examined the e¡ects of overexpressed PLCN1 on
[3H]InsP content of NRVM. NRVM were labeled with
[3H]inositol and treated for 48 h with control virus (Ad-MX
NRVM) or with virus encoding PLCN1 (Ad-PLCN1 NRVM).
Fig. 1. Overexpressed PLCN1 does not enhance InsP responses to Ca2þ. [3H]Inositol-labeled Ad-MX NRVM and Ad-PLCN1 NRVM were
treated with 10 WM A23187 in the presence of 10 mM LiCl for 20 min. [3H]InsPs were extracted and individual isomers separated and quanti-
¢ed. Open bars, vehicle control; ¢lled bars, A23187; striped boxes indicate PLCN1 overexpression. Results are [3H]InsPs, meanVS.E.M. of trip-
licate values from one of three experiments. **P6 0.01 relative to no additions; 2P6 0.01 relative to Ad-MX NRVM. PLCN1 expression in the
NRVM is indicated.
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[3H]InsPs were extracted and quanti¢ed. Total [3H]InsP con-
tent was higher in Ad-PLCN1 NRVM than in Ad-MX NRVM
indicating that the overexpressed enzyme was active and could
access substrate. This increase was primarily due to height-
ened Ins(4)P1, that accumulates in the presence of Liþ. Ins(4)-
P1 is the major ¢nal dephosphorylation product of Ins(1,4)P2
and Ins(1,4,5)P3. [3H]Ins(1,4,5)P3 was also increased by
PLCN1 overexpression most likely primarily re£ecting binding
to its PH domain (Fig. 1).
3.2. Overexpression of PLCN1 reduces the [3H]InsP response
to elevated Ca2+
The PLCN isoforms of PtdIns-speci¢c PLC are more Ca2þ-
sensitive than the L and Q isoforms and are therefore likely
mediators of Ca2þ-induced InsP responses. To establish
whether PLCN1 mediates Ca2þ-induced InsP responses in
NRVM, we measured [3H]InsP responses to increased Ca2þ
in [3H]inositol-labeled Ad-MX and Ad-PLCN1 NRVM.
NRVM were stimulated with the Ca2þ ionophore A23187
(10 WM) in the presence of LiCl for 20 min. Addition of
10 WM A23187 to Ad-MX NRVM caused an increase in
[3H]InsP content, involving increases in all of the InsP isomers
detected in the cells, as shown in Fig. 1. In marked contrast,
addition of A23187 failed to signi¢cantly increase total
[3H]InsPs over unstimulated levels in cells overexpressing
PLCN1 (Fig. 1). However, even though there was no signi¢-
cant increase in [3H]InsPs, signi¢cant rises in [3H]Ins(1,4,5)P3,
[3H]Ins(1,3,4)P3, [3H]Ins(1,4)P2 and [3H]Ins(1/3)P1 were ob-
served. This was balanced by a reduction in Ins(4)P1 most
likely re£ecting Ca2þ inhibition of its generation from
Ins(1,4)P2. INPP, the enzyme responsible for hydrolyzing to
Ins(4)P1, is inhibited by Ca2þ [26].
To further investigate the possible role of PLCN1 in medi-
ating Ca2þ-induced [3H]InsP responses in NRVM, we ex-
pressed full length antisense PLCN1 (Ad-anti-PLCN1 NRVM)
and measured [3H]InsP responses to 10 WM A23187. Expres-
sion of antisense PLCN1 (100 pfu/cell) reduced the expression
of PLCN1 in NRVM but did not alter the [3H]InsP response to
A23187 (Fig. 2).
3.3. Ins(1,4,5)P3 does not inhibit Ca
2+-stimulated [3H]InsP
responses in permeabilized NRVM
Altering the level of expression of PLCN1 did not provide
evidence to support a major role for PLCN1 in Ca2þ responses
in NRVM. We next sought evidence of a role for PLCN1 at
physiological expression levels in non-transfected NRVM.
The activity of PLCN but not the other isoforms of PLC is
inhibited by Ins(1,4,5)P3 with an EC50 of 100^300 nM [27^29].
To further investigate the role of PLCN1 in Ca2þ-mediated
responses in NRVM, we examined the e¡ect of high concen-
trations of Ins(1,4,5)P3 on [3H]InsP responses to elevations in
Ca2þ in permeabilized cells. [3H]Inositol-labeled NRVM were
permeabilized, and maintained in ‘intracellular’ medium with
Ca2þ bu¡ered at 0.1 WM. [3H]InsP responses were initiated by
increasing Ca2þ to 10 WM for 1 or 20 min. [3H]InsPs were
extracted and quanti¢ed. Heightened Ca2þ caused increases in
[3H]InsPs at both time points and Ins(1,4,5)P3, even at 300
WM, did not inhibit the Ca2þ-induced response (Fig. 3A). This
argues against a major involvement of PLCN isoforms.
To ensure that the Ins(1,4,5)P3 added to the medium could
access intracellular targets, we examined the e¡ect of
Ins(1,4,5)P3 on another intracellular enzyme, INPP, which
hydrolyzes Ins(1,4)P2 to Ins(4)P1. We ¢rst demonstrated
that recombinant INPP is inhibited by high concentrations
of Ins(1,4,5)P3. Recombinant INPP was incubated with and
Fig. 2. Decreasing the expression of PLCN1 using antisense con-
structs does not reduce [3H]InsP responses to A23187. [3H]Inositol-
labeled Ad-MX NRVM or Ad-anti-PLCN1 NRVM were incubated
for 20 min with A23187 (10 WM) in the presence of LiCl. [3H]InsPs
were extracted and quanti¢ed. Open bars, vehicle control; ¢lled
bars, A23187. Results are total [3H]InsPs, meanVS.E.M. of tripli-
cate samples from one of three experiments. **P6 0.01 relative to
vehicle control. Expression of PLCN1 is shown. Similar changes
were observed in three experiments.
Fig. 3. Ins(1,4,5)P3 does not inhibit the [3H]InsP response to height-
ened Ca2þ in permeabilized NRVM. A: [3H]Inositol-labeled NRVM
were permeabilized and maintained in ‘intracellular’ medium with
Ca2þ bu¡ered to 0.1 WM. Total [3H]InsP responses were initiated by
increasing Ca2þ to 10 WM for 1 or 20 min, in the absence or pres-
ence of 300 WM Ins(1,4,5)P3 as indicated. B: Inhibition of INPP ac-
tivity by 300 WM Ins(1,4,5)P3. Left panel: Inhibition of the recombi-
nant INPP enzyme activity measured using 10 WM [3H]Ins(1,4)P2 as
substrate. Right panel: Inhibition of INPP activity in [3H]inositol-
labeled permeabilized cells measured from the ratio of the product
[3H]Ins(4)P1 to the substrate [3H]Ins(1,4)P2. Values shown are
meanVS.E.M., n=3. *P6 0.05 relative to no additions; 2P6 0.01
relative to no Ins(1,4,5)P3.
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without 300 WM Ins(1,4,5)P3 and activity measured as de-
scribed in Section 2. Ins(1,4,5)P3 caused an inhibition of
enzyme activity as shown in Fig. 3B, right panel. Then we
examined e¡ects of Ins(1,4,5)P3 on INPP activity in per-
meabilized NRVM, under similar conditions to those used
in the studies of Ca2þ-activated [3H]InsP responses.
[3H]Inositol-labeled NRVM were permeabilized and main-
tained in ‘intracellular’ medium, as described above. Addition
of 300 WM Ins(1,4,5)P3 to the medium reduced INPP activity
in permeabilized NRVM, as demonstrated by the selective
reduction in the ratio of the enzyme product [3H]Ins(4)P1 to
its substrate [3H]Ins(1,4)P2. The e¡ectiveness of Ins(1,4,5)P3 in
inhibiting INPP activity in permeabilized NRVM shows that
Ins(1,4,5)P3 added to the extracellular medium can access in-
tracellular enzymes and would therefore be expected to inhibit
PLCN1.
4. Discussion
We have recently reported two distinct pathways of InsP
generation in NRVM, one involving Ins(1,4,5)P3 generation
in response to elevated Ca2þ and the other principally involv-
ing generation of Ins(1,4)P2 in response to K1-adrenergic re-
ceptor activation [4]. Additionally we showed that the K1-ad-
renergic receptor response is mediated primarily by PLCL1
[23]. In the current study, we sought to identify the PLC iso-
form responsible for the Ca2þ response. Of the classes of
PtdIns-speci¢c PLCs, PLC-N isoforms are particularly sensi-
tive to activation by Ca2þ in the absence of other stimuli [15]
and thus it seemed likely that PLCN1 was responsible for the
Ca2þ-mediated generation of Ins(1,4,5)P3 in NRVM. In an
attempt to con¢rm this, we manipulated PLCN1 content in
NRVM using adenoviruses encoding sense or antisense PLCN1
sequences.
Adenoviral overexpression of PLCN1 increased basal
[3H]InsP content, indicating that the expressed PLCN1 was
catalytically active. Overexpressed PLCN1 also heightened
Ins(1,4,5)P3 content, in keeping with binding by its PH do-
main which has a high a⁄nity for Ins(1,4,5)P3. Despite the
fact that overexpressed PLCN1 was catalytically active and
localized appropriately, responses to the Ca2þ ionophore
A23187 were reduced, rather than increased, in PLCN1-over-
expressing cells. Increasing expression levels had failed to pro-
vide evidence that PLCN1 mediated Ca2þ responses in NRVM.
We next sought evidence for involvement of endogenous
PLCN1. In the ¢rst series of experiments endogenous expres-
sion of PLCN1 was reduced using adenoviruses encoding anti-
sense PLCN1. The ¢nding that Ca2þ-activated InsP responses
were not reduced argued against a requirement for PLCN1
(Fig. 2). As discussed above Ins(1,4,5)P3 binds PLCN isoforms
with high a⁄nity and inhibits their activity. In experiments
using permeabilized NRVM we showed that responses to
heightened Ca2þ were not inhibited by Ins(1,4,5)P3 at concen-
trations 1000 times higher than required for inhibition of
PLCN1 [27]. The lack of inhibitory e¡ect of Ins(1,4,5)P3 argues
against involvement of PLCN1.
Taken together studies using overexpression, reduced ex-
pression and selective inhibition of PLCN1 have failed to pro-
vide evidence that PLCN1 mediates Ca2þ-induced InsP re-
sponses in NRVM.
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